arrow
Back
O

Olli Kallioniemi

University of Helsinki

122H-index
954Paper Count
6.1WCitation Count
Published Papers 223
Publication Date
An AI-Health infrastructure for the Nordic region: technical foundations, data assets, and a roadmap for deployment
err2026-08-14
err0
PREAI
errOle A. Andreassen; Hakon Heimer; Dag Aarsland; Anders M. Dale; Daníel Gudbjartsson; Bo Jacobsson; Ingrid Kockum; Tuuli Lappalainen; Andres Metspalu; Lili Milani; Pål R. Njølstad; Aarno Palotie; Samuli Ripatti; Anders Sandvik; Olav B. Smeland; Hreinn Stefánsson; Kári Stefánsson; Marc Vaudel; Jaak Vilo; Thomas Werge; Søren Brunak; Olli Kallioniemi
errShare
errSave
Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities
err2025-11-06
err0
errOAAI
errFrida Rantanen; Astrid Murumägi; Mariliina Arjama; Katja Välimäki; Elina Multamäki; Tuomas Mirtti; Antti Rannikko; Teijo Pellinen; Daniela Ungureanu; Olli Kallioniemi
errShare
errSave
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
err2025-08-23
err0
errOAAI
errElisabetta Cozzi; Anne Neddermeyer; Xiangfu Zhong; Angelica María Gamboa-Cedeño; Dimitris C. Kanellis; Albin Österroos; My Björklund; Nona Struyf; Kasper Karlsson; Ying Qu; Alma Månsson; Tatjana Pandzic; Sofia Bengtzén; Christer Nilsson; Roland Fiskesund; Panagiotis Baliakas; Tom Erkers; Jiri Bartek; Olli-Pekka Kallioniemi; Hong Qian; Andreas Lennartsson; Sören Lehmann
errShare
errSave
Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancer
err2025-05-24
err0
errOAAI
errGreta Gudoityte; Osheen Sharma; Laura Leuenberger; Emelie Wallin; Josefin Fernebro; Päivi Östling; Rebecka Bergström; Johan Lindberg; Ulrika Joneborg; Olli Kallioniemi; Brinton Seashore-Ludlow
errShare
errSave
Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolism
err2025-04-23
err0
errOAAI
errYeon Chae, Soo; Jang, Se-Young; Kim, Jinhui; Hwang, Sehyun; Malani, Disha; Kallioniemi, Olli; Yun, Seung Gyu; Kim, Jong-Seo; Kim, Hugh I.
errShare
errSave
Evaluating feature extraction in ovarian cancer cell line co-cultures using deep neural networks
err2025-02-25
err0
errOAAI
errSharma, Osheen; Gudoityte, Greta; Minozada, Rezan; Kallioniemi, Olli P.; Turkki, Riku; Paavolainen, Lassi; Seashore-Ludlow, Brinton
errShare
errSave
Exploiting NRF2-ARE pathway activation in papillary renal cell carcinoma
err2024-12-20
err0
errOAAI
errAngori, Silvia; Lakshminarayanan, Harini; Banaei-Esfahani, Amir; Muhlbauer, Katharina; Bolck, Hella Anna; Kallioniemi, Olli; Pietiainen, Vilja; Schraml, Peter; Moch, Holger
errShare
errSave
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma
err2024-10-20
err0
errOAAI
errRoos-Mattila, Matilda; Kallio, Pauliina; Luck, Tamara J.; Polso, Minttu; Kumari, Romika; Mikkonen, Piia; Valimaki, Katja; Malmstedt, Minna; Ellonen, Pekka; Pellinen, Teijo; Heckman, Caroline A.; Mustonen, Harri; Puolakkainen, Pauli A.; Alitalo, Kari; Kallioniemi, Olli; Mirtti, Tuomas; Rannikko, Antti S.; Pietiainen, Vilja M.; Seppanen, Hanna E.
errShare
errSave
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts
err2024-05-01
err2
errOAAI
errOlesinski, Elyse A.; Bhatia, Karanpreet Singh; Wang, Chuqi; Pioso, Marissa S.; Lin, Xiao Xian; Mamdouh, Ahmed M.; Ng, Shu Xuan; Sandhu, Vedant; Jasdanwala, Shaista Shabbir; Yilma, Binyam; Bohl, Stephan; Ryan, Jeremy A.; Malani, Disha; Luskin, Marlise R.; Kallioniemi, Olli; Porkka, Kimmo; Adamia, Sophia; Chng, Wee Joo; Osato, Motomi; Weinstock, David M.; Garcia, Jacqueline S.; Letai, Anthony; Bhatt, Shruti
errShare
errSave
Interactive analysis of drug testing data for functional precision oncology with Breeze 2.0
err2024-03-22
err0
PREAI
errPotdar, Swapnil; Ianevski, Filipp; Ianevski, Aleksandr; Tanoli, Ziaurrehman; Wennerberg, Krister; Seashore-Ludlow, Brinton; Kallioniemi, Olli; Ostling, Paivi; Aittokallio, Tero; Saarela, Jani
errShare
errSave
Spatial profiling of inflamed tumor microenvironment of clear cell renal cell carcinoma
err2024-03-22
err0
PREAI
errPellinen, Teijo; Luomala, Lassi; Mattila, Kalle; Saila, Jenni; Hemmes, Annabrita; Valimaki, Katja; Bruck, Oscar; Paavolainen, Lassi; Nisen, Harry; Jarvinen, Petrus; Kallioniemi, Olli; Vainio, Paula; Jaakkola, Panu; Mirtti, Tuomas
errShare
errSave
FAP/aSMA association with tumor visibility and progression in prostate cancer
err2024-03-22
err0
PREAI
errSaila, Jenni; Lehto, Timo-Pekka; Schoonenberg, Annabrita; Valimaki, Katja; Erickson, Andrew; Rannikko, Antti; Kallioniemi, Olli; Mirtti, Tuomas; Pellinen, Teijo
errShare
errSave
Large scale drug response comparison across different neuroblastoma cell model systems
err2024-03-22
err0
PREAI
errPark, Se Whee; Liu, Ernest; Los, Aironas; Seashore-Ludlow, Brinton; Ostling, Paivi; Molenaar, Jan; Kallioniemi, Olli; Stenman, Jakob; Karlsson, Kasper
errShare
errSave
Advancing radiotherapy strategies for high-risk rhabdomyosarcoma: Unveiling BCLxL inhibition as a potent sensitizer to radiotherapy
err2024-03-22
err0
PREAI
errPark, Sammy Se Whee; Struyf, Nona; Erkers, Tom; Lehmann, Soren; Meister, Michael T.; Drost, Jarno; Holstege, Frank C.; Herold, Nikolas; Ostling, Paivi; Stenman, Jakob; Kallioniemi, Olli; Henter, Jan-Inge; Seashore-Ludlow, Brinton; Karlsson, Kasper
errShare
errSave
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
err2024-02-19
err0
errOAAI
errStruyf, Nona; Osterroos, Albin; Vesterlund, Mattias; Arnroth, Cornelia; James, Tojo; Sunandar, Stephanie; Mermelekas, Georgios; Bohlin, Anna; Hamberg Levedahl, Kerstin; Bengtzen, Sofia; Jafari, Rozbeh; Orre, Lukas M.; Lehtio, Janne; Lehmann, Soren; Ostling, Paivi; Kallioniemi, Olli; Seashore-Ludlow, Brinton; Erkers, Tom
errShare
errSave
Strategies to decrease inequalities in cancer therapeutics, care and preventionProceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023
err2024-01-22
err11
errOAAI
errRingborg, Ulrik; von Braun, Joachim; Celis, Julio; Baumann, Michael; Berns, Anton; Eggermont, Alexander; Heard, Edith; Heitor, Manuel; Chandy, Mammen; Chen, Chien-Jen; Costa, Alberto; De Lorenzo, Francesco; De Robertis, Edward M.; Dubee, Frederick Charles; Ernberg, Ingemar; Gabriel, Mariya; Helland, Aslaug; Henrique, Rui; Joensson, Bengt; Kallioniemi, Olli; Korbel, Jan; Krause, Mechthild; Lowy, Douglas R.; Michielin, Olivier; Nagy, Peter; Oberst, Simon; Paglia, Vincenzo; Parker, M. Iqbal; Ryan, Kevin; Sawyers, Charles L.; Schuz, Joachim; Silkaitis, Katherine; Solary, Eric; Thomas, David; Turkson, Peter; Weiderpass, Elisabete; Yang, Huanming
errShare
errSave
Phosphodiesterase 3A modulators sensitize tumor cells to Bcl-2/Bcl-xL inhibitors
err2023-12-01
err0
PREAI
errToivanen, Kirsi L. J.; Murumagi, Astrid; Arjama, Mariliina A.; Merikoski, Nanna J.; Salmikangas, Sami I.; Kallioniemi, Olli P.; Bohling, Tom O.; Sihto, Harri J.
errShare
errSave
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
err2023-10-31
err3
errOAAI
errAkerlund, Emma; Gudoityte, Greta; Moussaud-Lamodiere, Elisabeth; Lind, Olina; Bwanika, Henri Colyn; Lehti, Kaisa; Salehi, Sahar; Carlson, Joseph; Wallin, Emelie; Fernebro, Josefin; Ostling, Paivi; Kallioniemi, Olli; Joneborg, Ulrika; Seashore-Ludlow, Brinton
errShare
errSave
Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets
err2023-09-01
err4
errOAAI
errAngori, Silvia; Banaei-Esfahani, Amir; Muhlbauer, Katharina; Bolck, Hella A.; Kahraman, Abdullah; Karakulak, Tulay; Poyet, Cedric; Feodoroff, Michaela; Potdar, Swapnil; Kallioniemi, Olli; Pietiainen, Vilja; Schraml, Peter; Moch, Holger
errShare
errSave